Courtney Levit

Ms. Courtney Levit

University of Georgia - Athens
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2020 in Viruses
Verified
Journal Article
Open access
PDF file
MMMaria Fernanda Lay Mendoza
Maria Fernanda Lay Mendoza
MAMarissa Acciani
Marissa Acciani
Courtney LevitCourtney Levit
Courtney Levit
CMChristopher Santa Maria
Christopher Santa Maria
Melinda BrindleyMelinda Brindley
Melinda Brindley
Viral entry is the first stage in the virus replication cycle and, for enveloped viruses, is mediated by virally encoded glycoproteins. Viral glycoproteins have different receptor affinities and triggering mechanisms. We employed vesicular stomatitis virus (VSV), a BSL-2 enveloped virus that can incorporate non-native glycoproteins, to examine the entry efficiencies of diverse viral glycoproteins. To compare the glycoprotein-mediated entry efficiencies of VSV glycoprotein (G), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S), Ebola (EBOV) glycoprotein (GP), Lassa (LASV) GP, and Chikungunya (CHIKV) envelope (E) protein, we produced recombinant VSV (rVSV) viruses that produce the five glycoproteins. The rVSV virions encoded a nano luciferase (NLucP) reporter gene fused to a destabilization domain (PEST), which we used in combination with the live-cell substrate EndurazineTM to monitor viral entry kinetics in real time. Our data indicate that rVSV particles with glycoproteins that require more post-internalization priming typically demonstrate delayed entry in comparison to VSV G. In addition to determining the time required for each virus to complete entry, we also used our system to evaluate viral cell surface receptor preferences, monitor fusion, and elucidate endocytosis mechanisms. This system can be rapidly employed to examine diverse viral glycoproteins and their entry requirements.

20 May 2025 in Journal of Orthopaedics
Verified
Journal Article
Open access
Courtney LevitCourtney Levit
Courtney Levit
RDRyan Decook
Ryan Decook
JSJoseph Michael Schwab
Joseph Michael Schwab
TBThomas L. Bradbury
Thomas L. Bradbury
NGNatalie L. Gresham
Natalie L. Gresham
BNBrandon Naylor
Brandon Naylor
Manual broaching in hip arthroplasty for femoral neck fractures (FNFx) may introduce variability in force application, increasing the risk of periprosthetic fractures. Automated impaction devices (AID) deliver consistent, uniform force vectors during femoral preparation, potentially reducing implant-bone mismatch, stem subsidence, and fracture risk. This study evaluates early complication rates following AID use in hip arthroplasty for FNFx. A retrospective cohort study was conducted on consecutive patients undergoing total hip arthroplasty (THA) or hemiarthroplasty (HA) for FNFx by two surgeons between January 1, 2019, and June 1, 2023. All patients received a cementless femoral stem implanted with an AID and had a minimum 30-day follow-up. Outcomes assessed included 30-day revision-free stem survivorship, intraoperative and postoperative periprosthetic fractures, femoral component subsidence, and 30-day reoperation and readmission rates. The cohort included 118 patients [72.0 % women; mean age 77.4 (range, 52-95) years], with 82 (69.5 %) undergoing THA and 36 (30.5 %) HA. One intraoperative fracture (0.8 %, Vancouver AG) and one postoperative fracture (0.8 %, Vancouver B1) occurred. The 30-day reoperation rate was 3.4 % (n = 4), and the readmission rate was 16.3 % (n = 15). Mild femoral component subsidence occurred in 1.7 % (n = 2) without evidence of loosening. No femoral stem revisions were reported within 30 days, yielding a 100 % short-term survivorship rate. Early outcomes suggest that AID use in hip arthroplasty for FNFx is associated with low rates of periprosthetic fracture, subsidence, and early complications. Further prospective studies are needed to assess long-term outcomes.